Erste Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Hold |
18,200
| – | – | 0.02% | 366 |
|
|
2025
Q1 | $3.35M | Hold |
18,200
| – | – | 0.04% | 256 |
|
|
2024
Q4 | $2.9M | Hold |
18,200
| – | – | 0.04% | 283 |
|
|
2024
Q3 | $3.22M | Hold |
18,200
| – | – | 0.04% | 275 |
|
|
2024
Q2 | $3.33M | Hold |
18,200
| – | – | 0.04% | 264 |
|
|
2024
Q1 | $3.23M | Hold |
18,200
| – | – | 0.04% | 265 |
|
|
2023
Q4 | $2.33M | Buy |
18,200
+12,800
| +237% | +$1.64M | 0.03% | 278 |
|
|
2023
Q3 | $637K | Hold |
5,400
| – | – | 0.01% | 383 |
|
|
2023
Q2 | $625K | Hold |
5,400
| – | – | 0.01% | 399 |
|
|
2023
Q1 | $428K | Hold |
5,400
| – | – | 0.01% | 436 |
|
|
2022
Q4 | $431K | Hold |
5,400
| – | – | 0.01% | 436 |
|
|
2022
Q3 | $381K | Hold |
5,400
| – | – | 0.01% | 449 |
|
|
2022
Q2 | $349K | Hold |
5,400
| – | – | 0.01% | 464 |
|
|
2022
Q1 | $361K | Buy |
+5,400
| New | +$361K | 0.01% | 463 |
|